HSA — authorised 25 March 2020
- Marketing authorisation holder: CELGENE INTL
- Status: likely_approved
HSA authorised Zeposia on 25 March 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 25 March 2020.
CELGENE INTL holds the Singaporean marketing authorisation.